RCMI Coordinating Center (RCMI CC) Header Logo

Search Results (738)

Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.Academic Article Why?
Advancements in small molecule drug design: A structural perspective.Academic Article Why?
Prodrug and antedrug: two diametrical approaches in designing safer drugs.Academic Article Why?
Chitrala, Kumaraswamy NaiduPerson Why?
Multi-Target, Mechanism-Based Drug Design for the Treatment of Breast Cancer: SynGrant Why?
A rationally designed anticancer drug targeting a unique binding cavity of tubulin.Academic Article Why?
Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design.Academic Article Why?
Leszczynski, JerzyPerson Why?
Designer DrugsConcept Why?
An informatics approach to assess pediatric pharmacotherapy: design and implementation of a hospital drug utilization system.Academic Article Why?
Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil.Academic Article Why?
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.Academic Article Why?
Genome-Targeted Drug Design: Understanding the Netropsin-DNA Interaction.Academic Article Why?
Characterizing a small molecule of Streptococcus cristatus for HIV drug designGrant Why?
Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose.Academic Article Why?
Per Page    Page  of 50last Nextnext
Search Criteria
  • Drug
  • Designing
Filter by Type
Click "Why?" to see why an item matched the search.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support